JPMorgan Chase & Co’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.71M | Sell |
438,349
-263,153
| -38% | -$2.23M | ﹤0.01% | 2920 |
|
2025
Q1 | $5.64M | Sell |
701,502
-225,796
| -24% | -$1.82M | ﹤0.01% | 2581 |
|
2024
Q4 | $8.33M | Buy |
927,298
+424,482
| +84% | +$3.81M | ﹤0.01% | 2378 |
|
2024
Q3 | $3.69M | Sell |
502,816
-4,218
| -0.8% | -$30.9K | ﹤0.01% | 2824 |
|
2024
Q2 | $2.9M | Buy |
507,034
+199,103
| +65% | +$1.14M | ﹤0.01% | 2853 |
|
2024
Q1 | $1.54M | Buy |
307,931
+88,828
| +41% | +$445K | ﹤0.01% | 3314 |
|
2023
Q4 | $1.97M | Sell |
219,103
-9,416
| -4% | -$84.7K | ﹤0.01% | 3150 |
|
2023
Q3 | $1.78M | Sell |
228,519
-163,899
| -42% | -$1.27M | ﹤0.01% | 3060 |
|
2023
Q2 | $3.8M | Buy |
392,418
+180,476
| +85% | +$1.75M | ﹤0.01% | 2675 |
|
2023
Q1 | $2.32M | Buy |
211,942
+70,932
| +50% | +$777K | ﹤0.01% | 2957 |
|
2022
Q4 | $610K | Buy |
141,010
+65,446
| +87% | +$283K | ﹤0.01% | 3654 |
|
2022
Q3 | $568K | Buy |
75,564
+3,290
| +5% | +$24.7K | ﹤0.01% | 3666 |
|
2022
Q2 | $726K | Buy |
72,274
+64,649
| +848% | +$649K | ﹤0.01% | 3665 |
|
2022
Q1 | $94K | Buy |
7,625
+4,114
| +117% | +$50.7K | ﹤0.01% | 4772 |
|
2021
Q4 | $80K | Sell |
3,511
-2,499
| -42% | -$56.9K | ﹤0.01% | 4910 |
|
2021
Q3 | $133K | Sell |
6,010
-85
| -1% | -$1.88K | ﹤0.01% | 4582 |
|
2021
Q2 | $79K | Buy |
+6,095
| New | +$79K | ﹤0.01% | 4839 |
|
2021
Q1 | – | Sell |
-60
| Closed | -$1K | – | 5239 |
|
2020
Q4 | $1K | Buy |
+60
| New | +$1K | ﹤0.01% | 4811 |
|
2020
Q1 | – | Sell |
-4,000
| Closed | -$81K | – | 4649 |
|
2019
Q4 | $81K | Buy |
+4,000
| New | +$81K | ﹤0.01% | 4091 |
|
2019
Q3 | – | Hold |
0
| – | – | – | 4759 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 4816 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 4830 |
|
2018
Q4 | – | Hold |
0
| – | – | – | 4841 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 4807 |
|